Skip to main content
Journal ArticleOPEN ACCESS

Why Diverse Clinical Trial Participation Matters

  • Schwartz A
  • Alsan M
  • Morris A
  • et al.
New England Journal of Medicine (2023) 388(14) 1252-1254
DOI: 10.1056/nejmp2215609
68Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

Abstract

Why Diverse Clinical Trial Participation Matters For efforts focused on increasing diversity in clinical trials, the promise of knowledge generation shouldn’t overshadow the goals of improving the ...

Cite

CITATION STYLE

APA

Schwartz, A. L., Alsan, M., Morris, A. A., & Halpern, S. D. (2023). Why Diverse Clinical Trial Participation Matters. New England Journal of Medicine, 388(14), 1252–1254. https://doi.org/10.1056/nejmp2215609

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free